NCT00469716View on ClinicalTrials.gov

Hypertonic Saline-hetastarch in Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Postoperative Cardiorespiratory Failure
Interventions
DRUG

Hypertonic saline (7.2%) hetastarch (6 %)(200/0.5)

Trial Locations (1)

5021

Section for thoracic and cardiovascular surgery, Haukeland University Hospital, Bergen

All Listed Sponsors
lead

Haukeland University Hospital

OTHER

NCT00469716 - Hypertonic Saline-hetastarch in Cardiac Surgery | Biotech Hunter | Biotech Hunter